Merck closes $8.0 billion bond offering across eight note series due 2029 to 2065
Merck & Co. closed an underwritten public offering of eight series of notes on December 4, 2025, totaling $8.0 billion in principal, issued under an existing shelf registration. The filing discloses the terms and legal documents for the debt but does not state how the company plans to use the proceeds, so its effect on shareholders depends on details outside this filing.
Key points
- Eight series of notes closed on December 4, 2025, ranging from $500 million floating rate notes due 2029 to $1.5 billion notes due 2055
- Fixed-rate coupons range from 3.850% on the 2029 Notes to 5.700% on the 2065 Notes
- Notes were issued under an indenture dated January 6, 2010, with U.S. Bank Trust National Association as trustee
The filing
Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 04, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.